Alcon AG | ALC - Ebitda

Aktienkurs
61.20
Täglich Wechseln
1.88 3.17%
Monatlich
-2.39%
Jährlich
-13.22%
Q2 Prognose
58.80




Ebitda Veränderung Datum
AstraZeneca USD 5.23B 272M 2025-09
Bayer EUR 1.97B 457M 2025-12
Essilor EUR 3.09B 356M 2024-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Philips EUR 738M 9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Smith & Nephew USD 796M 139M 2025-12
UCB EUR 1.6B 570M 2025-12